loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

List of Certificates of Suitability (CEPs) for r1_cep_2010_115___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CURIA SPAIN S.A.U. Boecillo ES (1)

filter

01 Dorzolamide hydrochloride (1)

filter

01 U.S.A (1)

filter

01 Valid (1)

URL Supplier Web Content
R1-CEP 2010-115 - Rev 03
Valid
Chemical
2021-11-15
2359
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-115 - Rev 03 of Curia Spain S.a.u. Boecillo Es

Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-115 - Rev 03 of Curia Spain S.a.u. Boecillo Es 1

20

Curia Spain S.a.u. Boecillo Es, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.

One of their significant offerings is Dorzolamide hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-115 - Rev 03

This Chemical Type CEP, issued on November 15, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2359 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY